Hope for thousands of MS patients as 'life-changing' drug now on NHS in England
Reported byBBC Health ↗·Sourced by Goodlede
Fampridine, the first drug to help multiple sclerosis patients walk, is now available on the NHS in England, with up to 5,000 people eligible annually. Clinical trials showed around 40% of patients taking the drug had improvements in walking speed and duration.
Only about 5,000 people per year will be eligible based on the extent of their walking difficulties, and patients must show 'clear benefit' during a trial period to continue.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at BBC Health
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede